World Health Organization. (2020). Chagas disease (American trypanosomiasis). WHO Fact Sheet.
[2]
Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388-1402.
[3]
Bern C. Chagas disease in the immunosuppressed host. Curr Opin Infect Dis. 2012;25(4):450-457.
[4]
Dias JC, et al. Natural history of Chagas disease. Parasitol Res. 2011;108(2):533-535.
[5]
Patterson NM, et al. Autonomic dysfunction in chronic Chagas disease. J Neurol Sci. 2019;407:116785.
[6]
Macedo AM, et al. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease. Mem Inst Oswaldo Cruz. 2014;99(5):489-501.
[7]
Nunes MC, et al. Chagas disease: overview of aneurysm, stroke, and heart failure. Curr Hypertens Rep. 2018;20(1):7.
[8]
Gascón J, et al. New, improved, and empowered therapeutic options for Chagas disease. Expert Opin Pharmacother. 2019;20(1):85-94.
[9]
Perez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391(10115):82-94.
[10]
Almeida EA, et al. Chagas disease: still a serious health problem. Rev Soc Bras Med Trop. 2018;51(5):589-596.